Sylvain Anselme
Papers
2
Total Citations
7
H-Index
1
About
Sylvain Anselme is a pioneering surgeon at the forefront of robotic-assisted surgery, with a focused expertise in minimally invasive general and urologic procedures. His major contributions center on the clinical validation and feasibility assessment of the novel Hugo™ Robotic-Assisted Surgery (RAS) System, an emergent platform poised to expand access to robotic surgery. In his landmark 2024 study, the first general surgery-focused clinical trial in Korea, Anselme demonstrated the safety and efficacy of the Hugo™ system for cholecystectomy, achieving 6 citations and establishing a critical benchmark for its adoption. He further broadened this work with a concurrent urologic and general surgery feasibility study, laying the groundwork for multi-specialty robotic applications. Anselme’s research directly addresses the pressing need for evidence-based evaluation of new surgical technologies, offering early clinical data that guides both surgeons and healthcare systems. By pioneering these initial Korean studies, he has not only advanced the technical understanding of the Hugo™ system but also positioned himself as a key figure in the global transition toward next-generation robotic surgery, with his work informing future large-scale trials and clinical practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2